What is the correct way to take Deflazacort?

Deflazacort, a glucocorticoid, plays a central role in the management of Duchenne muscular dystrophy. Its medication method not only involves precise calculation of dosage, but also requires individualized adjustments based on the patient's age, weight, and whether there are drug interactions. The correct way of taking medication can maximize the effect of the drug in delaying disease progression while reducing the risk of potential adverse reactions.

Based on the guidelines and FDA-approved instructions, the standard recommended dose of Deflazacort is 0.9 mg/kg daily, usually taken orally once daily. Doses need to be calculated based on patient weight and rounded to the nearest available tablet strength. For children 2 years of age and older, the recommended dosage is the same as for adults, as the pharmacokinetic profile is not significantly different. It is worth noting that for long-term treatment patients, the dose is not static, but needs to be dynamically evaluated and adjusted based on clinical efficacy, tolerability and adverse reactions.

At the same time,Deflazacort requires extreme caution regarding drug interactions. Studies have shown that when patients are combined with moderate or strong CYP3A4 inhibitors, such as some antifungal drugs, antiviral drugs, etc., the metabolism of Deflazacort in the body will be significantly slowed down, and the blood drug concentration will increase, increasing the risk of side effects. Therefore, for such patients, the recommended dose needs to be reduced to 1/3 of the original dose to avoid complications caused by drug accumulation. Doctors often review the patient's complete medication list before issuing a prescription and adjust the plan accordingly.

The timing of medication is also an important factor affecting the efficacy. Deflazacort, usually taken in the morning with food, helps reduce gastrointestinal discomfort and aligns with the body's endogenous cortisol secretion rhythm, thereby improving tolerance. During long-term treatment, patients should not stop taking the drug or reduce the dose suddenly, otherwise it may cause adrenal insufficiency.

Reference: https://www.drugs.com/mtm/deflazacort.html